Central Glass (4044) Q1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2024 earnings summary
21 Oct, 2026Executive summary
Net sales were ¥34,830 million, down 10.7% year-over-year; operating profit rose 3.3% to ¥2,940 million.
Ordinary profit increased 9.2% to ¥4,190 million, and profit attributable to owners of parent rose 6.4% to ¥3,012 million.
Comprehensive income reached ¥4,346 million, up 2.4% year-over-year.
Financial highlights
Gross profit improved to ¥10,079 million from ¥9,582 million year-over-year.
Basic EPS rose to ¥121.57 from ¥114.25.
Q1 exchange-rate assumption/reference was ¥149 per US dollar versus ¥132 year-over-year; CIF crude oil was $87.5/bbl versus $82.9.
Outlook and guidance
FY2024 forecast remained unchanged from May 10: net sales ¥156,000 million, operating profit ¥11,000 million, ordinary profit ¥12,500 million and parent-attributable profit ¥10,000 million.
Full-year EPS is forecast at ¥403.55; annual dividend forecast remains ¥170 per share.
FY2024 sales forecasts: Chemicals ¥93,500 million and Glass ¥62,500 million; operating-profit forecasts are ¥8,500 million and ¥2,500 million, respectively.
Latest events from Central Glass
- New semiconductor materials support a ¥470億 FY2030 sales target.4044
Investor update - Higher H1 sales masked sharp profit declines, prompting lower FY2023 guidance.4044
Q2 2023 - Sales growth was offset by lower operating profit and net income.4044
Q1 2023 - FY2023 beat profit forecasts, but FY2024 earnings are expected to retreat.4044
Q4 2023 - Stronger glass sales could not offset lower chemical earnings and reduced extraordinary income.4044
Q3 2023 - Weak demand cut nine-month results and FY2024 forecasts; the ¥170 dividend was maintained.4044
Q3 2024 - H1 earnings fell on weaker demand and a share-sale loss; FY guidance was unchanged.4044
Q2 2024 - FY2025 sales edge higher, but operating profit falls amid weak demand and tariffs.4044
Q4 2024 - H1 operating profit fell 47.3% amid electrolyte pressure; FY2025 guidance was cut.4044
Q2 2025